F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization

Magnetic Resonance Imaging

Volumn 22, Issue 2, 2004, Pages 229-236

  Schmidt, Matthias ^a   Voth, Eberhard ^a   Schneider, Christian A ^b   Theissen, Peter ^a   Wagner, Rainer ^b   Baer, Frank M ^b   Schicha, Harald ^a  

^a Klin und Poliklin F Nuklearmed   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

18F Fluorodeoxyglucose; Inotropic agents; Magnetic resonance imaging; Myocardial infarction; Revascularization

Indexed keywords

DOBUTAMINE; FLUORINE 18; FLUORODEOXYGLUCOSE;

ADULT; AGED; AKINESIA; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICULOGRAPHY; HUMAN; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CORONARY ANGIOGRAPHY; DOBUTAMINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; SENSITIVITY AND SPECIFICITY; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED; VENTRICULAR FUNCTION, LEFT;

EID: 1542329017     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2003.07.006     Document Type: Article

References (32)

1. Gould K.L. Myocardial viability. What does it mean and how to measure it? Circulation. 83:1991;333-335.
2. Brunken R., Tillisch J., Schwaiger M., Child J.S., Marshall R., Mandelkern M., Phelps M.E., Schelbert H.R. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation. 73:1986;951-963.
3. Tamaki N., Yonekura Y., Yamashita K., Saji H., Magata Y., Senda M., Konishi Y., Hirata K., Ban T., Konishi J. Positron emission tomography using fluorine-18- deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 64:1989;860-885.
4. Pierard L.A., de Landsheere C.M., Berthe C., Rigo P., Kulbertus H.E. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography. J Am Coll Cardiol. 15:1990;1021-1031.
5. Baer F.M., Voth E., Schneider C.A., Theissen P., Schicha H., Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation. 91:1995;1006-1015.
6. Bax J.J., Wijns W., Cornel J.H., Visser F.C., Boersma E., Fioretti P.M. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease comparison of pooled data. J Am Coll Cardiol. 30:1997;1451-1460.
7. Schneider C.A., Voth E., Gawlich S., Baer F.M., Horst M., Schicha H., Erdmann E., Sechtem U. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction importance of infarct location adjusted thresholds. J Am Coll Cardiol. 32:1998;648-654.
8. Schelbert H.R. Positron emission tomography for the assessment of myocardial viability. Circulation. 84:1991;I122-I131.
9. Perrone-Filardi P., Bacharach S.L., Dilsizian V., Maurea S., Marin-Neto J.A., Arrighi J.A., Frank J.A., Bonow R.O. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol. 20:1992;161-168.
10. Baer F.M., Theissen P., Schneider C.A., Voth E., Sechtem U., Schicha H., Erdmann E. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 31:1998;1040-1048.
11. Atkinson D.J., Edelman R.R. Cineangiography of the heart in a single breath hold with a segmented turbo FLASH sequence. Radiology. 178:1991;357-360.
12. Baer F.M., Smolarz K., Theissen P., Voth E., Schicha H., Sechtem U. Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging. Eur Heart J. 15:1994;97-107.
13. Wienhard K., Eriksson L., Grootoonk S., Casey M., Pietrzyk U., Heiss W.D. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr. 16:1992;804-813.
14. Nesto R.W., Cohn L.H., Collins J.J., Wynne J., Holman L., Cohn P.F. Inotropic contractile reserve a useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol. 50:1982;39-44.
15. Kloner R.A., Bolli R., Marban E., Reinlib L., Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning an NHLBI workshop. Circulation. 97:1998;1848-1867.
16. Baer F.M., Voth E., Deutsch H.J., Schneider C.A., Horst M., de Vivie E.R., Schicha H., Erdmann E., Sechtem U. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol. 28:1996;60-69.
17. Higgins C.B., Lanzer P., Stark D., Botvinik E., Schiller N.B., Crooks L., Kaufmann L., Lipton M.J. Imaging by nuclear magnetic resonance in patients with chronic ischemic heart disease. Circulation. 69:1984;523-531.
18. Akins W.E., Hill J.A., Sievers K.W., Conti C.R. Assessment of left ventricular wall thickness in healed myocardial infarction by magnetic resonance imaging. Am J Cardiol. 59:1987;24-28.
19. Dubnow M.H., Burchell H.B., Titus J.L. Postinfarction ventricular aneurysm. A clinico-morphologic and electrocardiographic study of 80 cases. Am Heart J. 70:1965;753-760.
20. Roberts C.S., Maclean D., Maroko P., Kloner R.A. Early and late remodeling of the left ventricle after acute myocardial infarction. Am J Cardiol. 54:1984;407-410.
21. Gerber B.L., Vanoverschelde J.L., Bol A., Michel C., Labar D., Wijns W., Melin J.A. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation. 94:1996;651-659.
22. Bonow R.O., Dilsizian V., Cuocolo A., Bacharach S.L. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation. 83:1991;26-37.
23. Gould K.L., Yoshida K., Hess M.J., Haynie M., Mullani N., Smalling R.W. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med. 32:1991;1-9.
24. Klow N.E., Smith H.J., Gullestad L., Seem E., Endresen K. Outcome of bypass surgery in patients with chronic ischemic left ventricular dysfunction. Predictive value of MR imaging. Acta Radiol. 38:1997;76-82.
25. Gunning M.G., Anagnostopoulos C., Knight C.J., Pepper J., Burman E.D., Davies G., Fox K.M., Pennell D.J., Ell P.J., Underwood S.R. Comparison of 201T1, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation. 98:1998;1869-1874.
26. Baumgartner H., Porenta G., Lau Y.K., Wutte M., Klaar U., Mehrabi M., Siegel R.J., Czernin J., Laufer G., Sochor H., Schelbert H., Fishbein M.C., Maurer G. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT correlation with histopathology in explanted hearts. J Am Coll Cardiol. 32:1998;1701-1708.
27. Cornel J.H., Bax J.J., Elhendy A., Maat A.P., Kimman G.J., Geleijnse M.L., Rambaldi R., Boersma E., Fioretti P.M. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol. 31:1998;1002-1010.
28. Melon P.G., de Landsheere C.M., Degueldre C., Peters J.L., Kulbertus H.E., Pierard L.A. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction implications for identification of myocardial viability. J Am Coll Cardiol. 30:1997;1651-1659.
29. Sambuceti G., Giorgetti A., Corsiglia L., Marini C., Schneider-Eicke J., Brunelli C., Marzullo P., L'Abbate A., Capponnetto S., Parodi O. Perfusion-contraction mismatch during inotropic stimulation in hibernating myocardium. J Nucl Med. 39:1998;396-402.
30. Yang P.C., Kerr A.B., Liu A.C., Liang D.H., Hardy C., Meyer C.H., Macovski A., Pauly J.M., Hu B.S. New real-time interactive cardiac magnetic resonance imaging system complements echocardiography. J Am Coll Cardiol. 32:1998;2049-2056.
31. Klein C., Nekolla S.G., Bengel F.M., Momose M., Sammer A., Haas F., Schnackenburg B., Delius W., Mudra H., Wolfram D., Schwaiger M. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Comparison with positron emission tomography. Circulation. 105:2002;162-167.
32. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., Klocke F.J., Bonow R.O., Judd R.M. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 343:2000;1445-1453.